Evidence map›Paper›PMID 33055224›Full record

ArticleG3 (Bethesda, Md.)2020

Programmed Cell Death 2-Like (

Brendan J Houston, Manon S Oud, Daniel M Aguirre, D Jo Merriner, Anne E O'Connor, Ozlem Okutman, Stéphane Viville, Richard Burke, Joris A Veltman, Moira K O'Bryan

Open access · goldAbstract read
In one paragraph

Article in G3 (Bethesda, Md.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 4 countries.

Brendan J HoustonSchool of Biological Sciences, Monash University, Clayton, Australia brendan.houston@monash.edu.ORCID 0000-0002-1078-756X
Manon S OudDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.ORCID 0000-0001-9513-3030
Daniel M AguirreSchool of Biological Sciences, Monash University, Clayton, Australia.
D Jo MerrinerSchool of Biological Sciences, Monash University, Clayton, Australia.
Anne E O'ConnorSchool of Biological Sciences, Monash University, Clayton, Australia brendan.houston@monash.edu.
Ozlem OkutmanLaboratoire de Diagnostic Génétique, UF3472-génétique de l'infertilité, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.ORCID 0000-0002-3796-2479
Stéphane VivilleLaboratoire de Diagnostic Génétique, UF3472-génétique de l'infertilité, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.ORCID 0000-0002-5088-3003
Richard BurkeSchool of Biological Sciences, Monash University, Clayton, Australia.ORCID 0000-0003-0086-0767
Joris A VeltmanDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.ORCID 0000-0002-3218-8250
Moira K O'BryanSchool of Biological Sciences, Monash University, Clayton, Australia.ORCID 0000-0001-7298-4940
Monash University · AUHôpitaux Universitaires de Strasbourg · FRRadboud University Medical Center · NLRadboud University Nijmegen · NL

Funding

Wellcome Trust 209451/Z/17/Z
6 · The paper itself

Abstract

Globozoospermia is a rare form of male infertility where men produce round-headed sperm that are incapable of fertilizing an oocyte naturally. In a previous study where we undertook a whole exome screen to define novel genetic causes of globozoospermia, we identified homozygous mutations in the gene

Indexed as

Embryonic DevelopmentInfertility, MaleAdultAnimalsApoptosisCarrier ProteinsDrosophila melanogasterFemaleHumansMaleMicePregnancySpermatozoaCarrier Proteinsacrosomeembryonic developmentmale infertilityPdcd2lsperm function

Identifiers

PMID33055224
PMCPMC7718740
OpenAlexW3092905668

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.